Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2019

Feb 13, 2020

SELL
$51.85 - $73.36 $206,622 - $292,339
-3,985 Closed
0 $0
Q3 2019

Nov 12, 2019

SELL
$40.05 - $57.47 $84,425 - $121,146
-2,108 Reduced 34.6%
3,985 $219,000
Q2 2019

Aug 13, 2019

BUY
$30.3 - $41.14 $184,617 - $250,666
6,093 New
6,093 $247,000
Q1 2019

May 14, 2019

SELL
$29.37 - $40.49 $210,112 - $289,665
-7,154 Closed
0 $0
Q4 2018

Feb 14, 2019

SELL
$30.16 - $43.0 $5,760 - $8,213
-191 Reduced 2.6%
7,154 $240,000
Q3 2018

Nov 13, 2018

BUY
$32.83 - $42.51 $5,515 - $7,141
168 Added 2.34%
7,345 $310,000
Q1 2018

May 15, 2018

BUY
$49.22 - $68.43 $56,947 - $79,173
1,157 Added 19.22%
7,177 $357,000
Q4 2017

Feb 14, 2018

SELL
$52.14 - $59.94 $84,206 - $96,803
-1,615 Reduced 21.15%
6,020 $325,000
Q3 2017

Nov 13, 2017

BUY
$51.16 - $58.21 $390,606 - $444,433
7,635
7,635 $443,000

Others Institutions Holding ANIK

About Anika Therapeutics, Inc.


  • Ticker ANIK
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 14,599,900
  • Market Cap $259M
  • Description
  • Anika Therapeutics, Inc., a joint preservation company, creates and delivers advancements in early intervention orthopedic care in the areas of osteoarthritis (OA) pain management, regenerative solutions, soft tissue repair, and bone preserving joint technologies in the United States, Europe, and internationally. The company develops, manufactur...
More about ANIK
Track This Portfolio

Track Blair William & CO Portfolio

Follow Blair William & CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Blair William & CO, based on Form 13F filings with the SEC.

News

Stay updated on Blair William & CO with notifications on news.